Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA Mounjaro weight loss plan pairs a once-weekly tirzepatide injection with a reduced-calorie diet and increased activity — and, for most people who complete it, results in clinically meaningful weight reduction over months rather than weeks. Tirzepatide activates two gut-hormone receptors at once, which is why appetite can fall more sharply than many people expect from the early doses. These are prescription-only medicines: a qualified prescriber assesses whether this plan is right for you before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before any treatment starts, a prescriber reviews your health history, current medicines, weight, BMI and any relevant conditions. This isn't a formality. The assessment determines the right starting point and flags anything that would make tirzepatide unsuitable, a history of pancreatitis, certain thyroid conditions, pregnancy or plans to conceive, for example.
At nume, a GPhC-registered Independent Prescriber reads your consultation the same day. Photo-ID verification and a live weight check happen before approval; for patients transferring from another provider, evidence of current treatment is reviewed too. The NHS tirzepatide patient information page lists conditions that require careful prescriber discussion, it's a useful reference before you consult.
Eligibility for private treatment follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol, obstructive sleep apnoea or type 2 diabetes. BMI alone doesn't decide things; the full picture matters.
The first pen contains 2.5 mg doses. That sounds modest, and it is, deliberately. The starter dose exists to let your digestive system adjust, not to drive weight loss from week one. Nausea, loose stools and fatigue are most common in the first days after each new dose level; they typically ease within a week or two as the body adapts.
Injection technique matters from the start. Mounjaro comes as a pre-filled KwikPen; you inject into the abdomen, thigh or upper arm, rotating sites each week. Most people find a consistent routine helps, some keep the pen in the fridge door and inject on the same morning weekly, so it becomes as ordinary as any other health habit. Storage is refrigerated at 2–8°C; the Patient Information Leaflet gives the exact room-temperature window for travel or short periods away from the fridge.
Your prescriber (not a protocol) decides when to move to the next dose. A step-up typically happens after four weeks at each level, but only when the previous dose is well tolerated. Rushing the titration is one of the most common reasons people experience avoidable side effects.
The meaningful weight-loss phase of a Mounjaro plan tends to coincide with the mid-to-higher dose range: 7.5 mg, 10 mg, 12.5 mg and eventually 15 mg if clinically appropriate. SURMOUNT-1 (a 72-week trial published in the New England Journal of Medicine) recorded around 20–21% average body-weight reduction at the 15 mg dose. That figure comes from a structured clinical trial; individual results vary, and no plan guarantees a specific outcome.
Alongside the injections, the dietary and activity components carry real weight (so to speak). Appetite suppression from tirzepatide makes a calorie deficit more achievable, but protein intake, hydration and some form of resistance or strength activity help preserve muscle mass as weight falls. A dietitian or GP can help structure this if you want formal support. The full picture of what Mounjaro weight loss involves covers the lifestyle elements in more detail.
For women using oral contraceptives, there's a specific practical note: NHS guidance advises adding a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill can be affected. Transdermal HRT (patches or gels) may be preferable to oral HRT for the same reason, discuss this with your prescriber.
If you're considering the weight loss jab Mounjaro as part of your ongoing treatment, it helps to understand that this isn't a one-time purchase. NICE's recommendation for tirzepatide (TA1026) includes a review point at six months: if less than 5% weight loss has been achieved at the highest tolerated dose, continuing is reconsidered. That's not a cliff edge, it's a built-in check that the plan is working for you.
Every repeat order at nume goes through a fresh clinical review before dispatch; there are no auto-renewals and no subscription mechanics. The cost context for ongoing treatment is worth understanding before you start, the background on Mounjaro UK pricing explains how the market has changed since Eli Lilly's list-price revision in September 2025. For a broader look at weight-loss treatment options, the weight-loss overview sets tirzepatide alongside other licensed approaches.
Long-term, most prescribers frame tirzepatide as a tool within a wider plan rather than a permanent solution to be maintained indefinitely. Exploring how Mounjaro affects weight over time, including what happens after treatment ends, weight maintenance strategies, lifestyle anchors and follow-up, is worth raising with your prescriber from the start, not as an afterthought. If you want a clearer sense of what early progress can look like, Mounjaro 8 week weight loss outcomes give a useful reference point for what patients often experience in the first two months. If you have questions at any point, the FAQs cover the most common ones, and our team is available seven days a week through the contact page.
If you're ready to explore whether this plan suits you, start your free consultation with the nume clinical team. There's no obligation, and your answers are reviewed by a real prescriber (not automated scoring) the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.